Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Challenges in recognizing treatment-related neuroendocrine prostate cancer.

Literature DB >> 23169519

Challenges in recognizing treatment-related neuroendocrine prostate cancer.

Himisha Beltran¹, Scott T Tagawa, Kyung Park, Theresa MacDonald, Matthew I Milowsky, Juan Miguel Mosquera, Mark A Rubin, David M Nanus.

Abstract

Entities: Disease

Mesh：

Year: 2012 PMID： 23169519 DOI： 10.1200/JCO.2011.41.5166

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

94 in total

1. The hypothalamic-pituitary-gonadal axis and prostate cancer: implications for androgen deprivation therapy.

Authors: Luis A Kluth; Shahrokh F Shariat; Christian Kratzik; Scott Tagawa; Guru Sonpavde; Malte Rieken; Douglas S Scherr; Karl Pummer
Journal: World J Urol Date: 2013-09-03 Impact factor: 4.226

Review 2. Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Authors: Ugo Testa; Germana Castelli; Elvira Pelosi
Journal: Medicines (Basel) Date: 2019-07-30

3. Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts.

Authors: Massimo Ammirante; Shabnam Shalapour; Youngjin Kang; Christina A M Jamieson; Michael Karin
Journal: Proc Natl Acad Sci U S A Date: 2014-09-29 Impact factor: 11.205

4. Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.

Authors: Jie-Fu Chen; Hao Ho; Jake Lichterman; Yi-Tsung Lu; Yang Zhang; Mitch A Garcia; Shang-Fu Chen; An-Jou Liang; Elisabeth Hodara; Haiyen E Zhau; Shuang Hou; Rafi S Ahmed; Daniel J Luthringer; Jiaoti Huang; Ker-Chau Li; Leland W K Chung; Zunfu Ke; Hsian-Rong Tseng; Edwin M Posadas
Journal: Cancer Date: 2015-05-14 Impact factor: 6.860

Challenges in recognizing treatment-related neuroendocrine prostate cancer.

1. The hypothalamic-pituitary-gonadal axis and prostate cancer: implications for androgen deprivation therapy.

Review 2. Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

3. Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts.

4. Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.

5. Neuroendocrine differentiation of prostate cancer.

Review 6. Translational and clinical implications of the genetic landscape of prostate cancer.

Review 7. The evolving role of cytotoxic chemotherapy in the management of patients with metastatic prostate cancer.

8. Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential.

Review 9. New strategies in prostate cancer: translating genomics into the clinic.

10. Rapid progression of mixed neuroendocrine carcinoma-acinar adenocarcinoma of the prostate: A case report.